Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
Triple negative breast cancer (TNBC) patients not attaining pathological Complete Response (pCR) after neo-adjuvant chemotherapy (NAC) have poor prognosis. We characterized 19 patients for somatic mutations in primary tumor biopsy and residual disease (RD) at surgery by 409 cancer-related gene seque...
Main Authors: | Serena Di Cosimo, Valentina Appierto, Marco Silvestri, Giancarlo Pruneri, Andrea Vingiani, Federica Perrone, Adele Busico, Secondo Folli, Gianfranco Scaperrotta, Filippo Guglielmo de Braud, Giulia Valeria Bianchi, Stefano Cavalieri, Maria Grazia Daidone, Matteo Dugo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1753 |
Similar Items
-
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
by: Carolina Reduzzi, et al.
Published: (2021-05-01) -
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy
by: Serena Di Cosimo, et al.
Published: (2020-02-01) -
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
by: Emanuela Minna, et al.
Published: (2020-01-01) -
Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
by: Marco Silvestri, et al.
Published: (2021-03-01) -
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
by: Serena Di Cosimo, et al.
Published: (2019-01-01)